Allianz Asset Management
DNA icon

Allianz Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Allianz Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.29M Buy
700,516
+250,728
+56% +$2.09M ﹤0.01% 1235
2025
Q4 		$3.74M Buy
449,788
+257,628
+134% +$2.77M ﹤0.01% 1269
2025
Q3 		$2.8M Buy
+192,160
New +$2.3M ﹤0.01% 1364
2024
Q2 		– Sell
-34,712
Closed -$1.61M – 2148
2024
Q1 		$1.61M Buy
34,712
+6,884
+25% +$356K ﹤0.01% 1260
2023
Q4 		$1.88M Hold
27,828
– – ﹤0.01% 1354
2023
Q3 		$2.01M Hold
27,828
– – ﹤0.01% 1433
2023
Q2 		$2.07K Buy
27,828
+5,000
+22% +$296K ﹤0.01% 2019
2023
Q1 		$1.21M Buy
22,828
+5,922
+35% +$375K ﹤0.01% 1611
2022
Q4 		$1.14M Hold
16,906
– – ﹤0.01% 1463
2022
Q3 		$2.11M Buy
+16,906
New +$2.01M ﹤0.01% 1215

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return